| Bioactivity | Risevistinel (NYX-783) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be used to inhibit cognitive impairment associated with neurodegenerative diseases, such as mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, Lewy body disease[1]. |
| Target | NMDA receptor |
| Name | Risevistinel |
| CAS | 2591344-26-0 |
| Formula | C14H23N3O4 |
| Molar Mass | 297.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Moskal, et al. Methods of treating disorders associated with elevated levels of antibodies that interact with the NMDA receptor by administering a spiro-β-lactam compound. World Intellectual Property Organization, WO2021021996 A1. 2021-02-04. |
Risevistinel
CAS: 2591344-26-0 F: C14H23N3O4 W: 297.35
Risevistinel (NYX-783) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be u
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.